Home Newsfeeds Raymond James Upgrades Profound Medical to Strong Buy

Raymond James Upgrades Profound Medical to Strong Buy

Raymond James analyst Rahul Sarugaser upgrades Profound Medical (NASDAQ:PROF) from Outperform to Strong Buy.

byBenzinga Newsdesk

November 4, 2022

1 minute read

Raymond James analyst Rahul Sarugaser upgrades Profound Medical (NASDAQ:PROF) from Outperform to Strong Buy.

Apple’s Hush-Hush Bonanza Search Engine Deal With Google Has Jumped $10B In Just 3 Years, According To This Analyst

By Ananya Gairola

October 11, 5:35 AM

Apple currently derives an estimated annual income ranging from $18 billion to $20 billion by designating Google as the default search engine on its iOS platform.

AAPL

Apple, Google, Other Tech Giants Used Illegally Mined Gold From Brazil’s Amazon Rainforest: Report

By Shivdeep Dhaliwal

July 25, 11:54 PM

Apple Inc (NASDAQ: AAPL) and Alphabet Inc's (NASDAQ: GOOGL) (NASDAQ: GOOG) Google are among a

AAPL

Ispire Technology Inc. Increases Q4 2023 Revenue Outlook For Cannabis Vaping Hardware; Sees Q4 Revenue $14M-$15M Vs $12M-15M Previous Est

By Happy Mohamed

June 29, 8:38 AM

Updated Projection of $14 Million to $15 Million, Representing 247% to 271% Year-Over-Year Growth from the Same Period 2022 Previous Projection was $12 Million to $15

ISPR

FDA Authorizes Pfizer/BioNTech And Moderna’s Bivalent COVID Shots For 6 Months Old

By Vandana Singh

December 8, 2:18 PM

The FDA has authorized COVID-19 shots from Moderna Inc (NASDAQ:MRNA) and Pfizer Inc (NYSE:PFE)/ BioNTech SE (NASDAQ:BNTX) targeting the original coronavirus and Omicron sub-variants…

BNTX

Raymond James Upgrades Profound Medical to Strong Buy

Related Posts

Apple’s Hush-Hush Bonanza Search Engine Deal With Google Has Jumped $10B In Just 3 Years, According To This Analyst

Apple, Google, Other Tech Giants Used Illegally Mined Gold From Brazil’s Amazon Rainforest: Report

Ispire Technology Inc. Increases Q4 2023 Revenue Outlook For Cannabis Vaping Hardware; Sees Q4 Revenue $14M-$15M Vs $12M-15M Previous Est

FDA Authorizes Pfizer/BioNTech And Moderna’s Bivalent COVID Shots For 6 Months Old